6
report
Nonprofits: A Growing Force in Drug Development
Shepherding a drug from discovery to the market is a complex process that involves many actors.
report
Stepping off the Sidelines: The Unrealized Potential of Strategic Ultra-High-Net-Worth Philanthropy
The challenges our world is facing today will take a concerted, collaborative effort, and high-impa
ct philanthropists are poised to lead that effort like never before.
+ Read More
report
Amyotrophic Lateral Sclerosis (ALS) A Giving Smarter Guide
ALS, commonly known as Lou Gehrig’s disease or motor neurone disease (MND), is a cruel disease that
has challenged patients, their families, and the medical community for generations.
+ Read More
article
Researchers Invited to Apply for Funding for Basic Science in Sarcoidosis
The Milken Institute Center for Strategic Philanthropy, in partnership with the Ann Theodore Foundat
ion (ATF), is pleased to announce a new Request for Proposals (RFP) focused on understanding the underlying biology of sarcoidosis, an immune dysregulati
+ Read More
article
Global Platform Launches to Transform Bipolar Disorder Research and Care
BD2 commits to finding answers for the 40 million individuals with bipolar disorder and those not ye
t diagnosed
+ Read More
article
Center for Strategic Philanthropy: Summer/Fall 2022 Newsletter
In This Newsletter
Reports and Resources
Program Updates
CSP and Partners in the News